HUTCHMED (China) Limited

HMDCFOTCHealthcare● Active

$2.90

+$0.74(+34.26%)

Market Cap$2.5B

P/E Ratio—

52W High$3.815

52W Low$2.16

Avg Volume26

Open$3.82

Beta0.37

Free Cash Flow Financials Revenue

HUTCHMED (China) Limited (HMDCF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

HMDCF · free cash flow · updated Jun 9, 2026

Core FCF metrics

HMDCF · FCF · TTM · margin & CAGR

Free cash flow was −$78.9M for FY2025 (fiscal year ending 2025-12-31), down 352.6% year-over-year The FCF margin was -14.4%.

FY2025 Free Cash Flow−$78.9M▼ -352.6% YoY

Trailing 12M (TTM)−$49.7Mtrailing 4 quarters sum

FCF Margin-14.4%−$78.9M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

HMDCF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$64.8M(14M)−$78.9M▼ 352.6%-14.4%

FY2024$497,000(18M)−$17.4M▼ 109.3%-2.8%

FY2023$219.3M(33M)$186.6M▲ +161.1%22.3%

FY2022−$268.6M(37M)−$305.3M▼ 38.1%-71.6%

FY2021−$204.2M(17M)−$221.0M▼ 170.7%-62.0%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

HMDCF · P/FCF · FCF yield · FCF per share

HUTCHMED (China) Limited (HMDCF) reported negative free cash flow of −$0.08B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

HMDCF · cash flow statement · operating / investing / financing

For FY2025, HUTCHMED (China) Limited generated −$64.8M in operating cash flow and spent 14M in capital expenditures, yielding −$78.9M in free cash flow.

Operating Activities

−$64.8M

Cash from core business operations

2025-12-31

Investing Activities

−$29.5M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$7.8M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$64.8M) − |CapEx| (14M) = FCF (−$78.9M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

HMDCF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

HUTCHMED (China) LimitedYOU

HMDCF

−$78.9M-352.6%-14.4%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

HUTCHMED (China) Limited (HMDCF) reported free cash flow of −$78.9M for FY2025 (fiscal year ending 2025-12-31), down 352.6% year-over-year. The FCF margin was -14.4%.

Based on available data, HUTCHMED (China) Limited has maintained positive free cash flow for at least 4 fiscal year(s). FCF peaked at $186.6M in FY2023.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

HMDCF free cash flow · 8 questions

HUTCHMED (China) Limited free cash flow was −$78.9M for FY2025, down 352.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$49.7M.

HMDCF free cash flowHMDCF FCFHMDCF FCF 2025HMDCF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · HUTCHMED (China) Limited · HUTCHMED (China) Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026